These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 34786786)

  • 1. Identifying dementia in Down syndrome with the Severe Impairment Battery, Brief Praxis Test and Dementia Scale for People with Learning Disabilities.
    Wallace ER; Harp JP; Van Pelt KL; Koehl LM; Caban-Holt AM; Anderson-Mooney AJ; Jicha GA; Lightner DD; Robertson WC; Head E; Schmitt FA
    J Intellect Disabil Res; 2021 Dec; 65(12):1085-1096. PubMed ID: 34786786
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Longitudinal assessment of dementia measures in Down syndrome.
    Koehl L; Harp J; Van Pelt KL; Head E; Schmitt FA
    Alzheimers Dement (Amst); 2020; 12(1):e12075. PubMed ID: 33225040
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primitive Reflexes and Dementia in Adults With Down Syndrome.
    Harp J; Koehl L; Van Pelt K; Head E; Jicha G; Robertson W; Lightner D; Lott I; Schmitt F
    Neurol Clin Pract; 2022 Feb; 12(1):6-13. PubMed ID: 36157622
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapid assessment of cognitive function in down syndrome across intellectual level and dementia status.
    Walsh DM; Doran E; Silverman W; Tournay A; Movsesyan N; Lott IT
    J Intellect Disabil Res; 2015 Nov; 59(11):1071-9. PubMed ID: 26031550
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cross-sectional versus longitudinal cognitive assessments for the diagnosis of symptomatic Alzheimer's disease in adults with Down syndrome.
    Videla L; Benejam B; Carmona-Iragui M; Barroeta I; Fernández S; Arranz J; Azzahchi SE; Altuna M; Padilla C; Valldeneu S; Pegueroles J; Montal V; Aranha MR; Vaqué-Alcázar L; Iulita MF; Alcolea D; Bejanin A; Videla S; Blesa R; Lleó A; Fortea J
    Alzheimers Dement; 2023 Sep; 19(9):3916-3925. PubMed ID: 37038748
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A preliminary study of cerebral blood flow, aging and dementia in people with Down syndrome.
    Thalman S; Van Pelt KL; Lin AL; Johnson NF; Jicha G; Caban-Holt A; Robertson W; Lightner D; Powell D; Head E; Schmitt F
    J Intellect Disabil Res; 2020 Dec; 64(12):934-945. PubMed ID: 32996650
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Screening for Dementia and Cognitive Decline in Adults With Down Syndrome: A Novel Approach Using the Informant Questionnaire on Cognitive Decline in the Elderly.
    Prado Mattar G; Uchida RR; Haddad GG; Shiozawa P; Rebouças da Silva MF; Hoexter MQ; Busatto GF; de Campos Bottino CM; Fonseca LM; Forlenza OV
    Alzheimer Dis Assoc Disord; 2022 Apr-Jun 01; 36(2):162-167. PubMed ID: 35293379
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cognitive and Behavioral Domains That Reliably Differentiate Normal Aging and Dementia in Down Syndrome.
    Harp JP; Koehl LM; Pelt KLV; Hom CL; Doran E; Head E; Lott IT; Schmitt FA
    Brain Sci; 2021 Aug; 11(9):. PubMed ID: 34573150
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frontal white matter integrity in adults with Down syndrome with and without dementia.
    Powell D; Caban-Holt A; Jicha G; Robertson W; Davis R; Gold BT; Schmitt FA; Head E
    Neurobiol Aging; 2014 Jul; 35(7):1562-9. PubMed ID: 24582640
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Establishing diagnostic thresholds for Alzheimer's disease in adults with Down syndrome: the Cambridge Examination for Mental Disorders of Older People with Down's Syndrome and Others with Intellectual Disabilities (CAMDEX-DS).
    Beresford-Webb JA; Mak E; Grigorova M; Daffern SJ; Holland AJ; Zaman SH
    BJPsych Open; 2021 Apr; 7(3):e79. PubMed ID: 33845926
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnosis of prodromal and Alzheimer's disease dementia in adults with Down syndrome using neuropsychological tests.
    Benejam B; Videla L; Vilaplana E; Barroeta I; Carmona-Iragui M; Altuna M; Valldeneu S; Fernandez S; Giménez S; Iulita F; Garzón D; Bejanin A; Bartrés-Faz D; Videla S; Alcolea D; Blesa R; Lleó A; Fortea J
    Alzheimers Dement (Amst); 2020; 12(1):e12047. PubMed ID: 32613076
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Down syndrome and dementia: seizures and cognitive decline.
    Lott IT; Doran E; Nguyen VQ; Tournay A; Movsesyan N; Gillen DL
    J Alzheimers Dis; 2012; 29(1):177-85. PubMed ID: 22214782
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Executive dysfunction and its association with personality and behaviour changes in the development of Alzheimer's disease in adults with Down syndrome and mild to moderate learning disabilities.
    Ball SL; Holland AJ; Treppner P; Watson PC; Huppert FA
    Br J Clin Psychol; 2008 Mar; 47(Pt 1):1-29. PubMed ID: 17681112
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The validity and reliability of the CAMDEX-DS for assessing dementia in adults with Down syndrome in Brazil.
    Fonseca LM; Haddad GG; Mattar GP; Oliveira MC; Simon SS; Guilhoto LM; Busatto GF; Zaman S; Holland AJ; Hoexter MQ; Bottino CM
    Braz J Psychiatry; 2019; 41(3):225-233. PubMed ID: 30365671
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessing Specific Cognitive Deficits Associated with Dementia in Older Adults with Down Syndrome: Use and Validity of the Arizona Cognitive Test Battery (ACTB).
    Sinai A; Hassiotis A; Rantell K; Strydom A
    PLoS One; 2016; 11(5):e0153917. PubMed ID: 27171413
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The modified CAMDEX informant interview is a valid and reliable tool for use in the diagnosis of dementia in adults with Down's syndrome.
    Ball SL; Holland AJ; Huppert FA; Treppner P; Watson P; Hon J
    J Intellect Disabil Res; 2004 Sep; 48(Pt 6):611-20. PubMed ID: 15312062
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Balance and Gait: Associations With Cognitive Impairment and Dementia in Individuals With Down Syndrome.
    Conceição ASGG; Sant Ana LFG; Mattar GP; de Fátima R Silva M; Ramos AR; Oliveira AM; Carvalho CL; Gonçalves OR; Varotto BLR; Martinez LD; Leduc V; Fonseca LM; Forlenza OV
    Alzheimer Dis Assoc Disord; 2023 Oct-Dec 01; 37(4):349-356. PubMed ID: 37788381
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma and CSF biomarkers for the diagnosis of Alzheimer's disease in adults with Down syndrome: a cross-sectional study.
    Fortea J; Carmona-Iragui M; Benejam B; Fernández S; Videla L; Barroeta I; Alcolea D; Pegueroles J; Muñoz L; Belbin O; de Leon MJ; Maceski AM; Hirtz C; Clarimón J; Videla S; Delaby C; Lehmann S; Blesa R; Lleó A
    Lancet Neurol; 2018 Oct; 17(10):860-869. PubMed ID: 30172624
    [TBL] [Abstract][Full Text] [Related]  

  • 19. (1)H-MRS metabolites in adults with Down syndrome: Effects of dementia.
    Lin AL; Powell D; Caban-Holt A; Jicha G; Robertson W; Gold BT; Davis R; Abner E; Wilcock DM; Schmitt FA; Head E
    Neuroimage Clin; 2016; 11():728-735. PubMed ID: 27330972
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.